Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 0.31623 | uM | 4 | 156.25 | 63.10 | 56.00 | 76.25 | 0.7344 | -0.3543 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 156.25 | 63.10 | 115.00 | 76.25 | 1.5082 | 8.0098 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 156.25 | 63.10 | 121.00 | 76.25 | 1.5869 | 9.8548 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 4 | 156.25 | 63.10 | 140.00 | 76.25 | 1.8361 | 17.5202 |
| SK-BR-3 | PLX-4720 | 10 | uM | 4 | 156.25 | 63.10 | 87.00 | 76.25 | 1.1410 | 2.2422 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 4 | 156.25 | 63.10 | 99.00 | 76.25 | 1.2984 | 4.2047 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 4 | 156.25 | 63.10 | 1667.00 | 76.25 | 21.8623 | 161547.6102 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 156.25 | 63.10 | 58.00 | 76.25 | 0.7607 | -0.2658 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 156.25 | 63.10 | 69.00 | 76.25 | 0.9049 | 0.3871 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 156.25 | 63.10 | 79.00 | 76.25 | 1.0361 | 1.2772 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 156.25 | 63.10 | 106.00 | 76.25 | 1.3902 | 5.6846 |
| SK-BR-3 | Nilotinib | 10 | uM | 4 | 156.25 | 63.10 | 545.00 | 76.25 | 7.1475 | 2689.2040 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 156.25 | 63.10 | 88.00 | 76.25 | 1.1541 | 2.3808 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 156.25 | 63.10 | 41.00 | 76.25 | 0.5377 | -0.7939 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 92.00 | 76.25 | 1.2066 | 2.9787 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 71.00 | 76.25 | 0.9312 | 0.5401 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 40.00 | 76.25 | 0.5246 | -0.8118 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 65.00 | 76.25 | 0.8525 | 0.1145 | |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 156.25 | 63.10 | 60.00 | 76.25 | 0.7869 | -0.1687 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 4 | 156.25 | 63.10 | 66.00 | 76.25 | 0.8656 | 0.1786 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 64.00 | 76.25 | 0.8393 | 0.0530 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 4 | 156.25 | 63.10 | 53.00 | 76.25 | 0.6951 | -0.4723 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 156.25 | 63.10 | 79.00 | 76.25 | 1.0361 | 1.2772 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 156.25 | 63.10 | 57.00 | 76.25 | 0.7475 | -0.3111 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 156.25 | 63.10 | 51.00 | 76.25 | 0.6689 | -0.5416 |